Enter your login e-mail to the account
Search
Search parameters
Search results
- PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles )
- Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - DNA repair and its reference to resistance to anticancer therapy
doc. MUDr. Mária Wagnerová, CSc., MUDr. Martina Čižmáriková, PhD., prof. MUDr. Anton Kohút, DrSc.,, prof. MUDr. Ladislav Mirossay, DrSc.
(4/2007, Review articles ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - The role of immunotherapy in gynaecological malignancies
MUDr. Róbert Biel, PhD., MBA, doc. MUDr. Igor Andrašina, CSc.
(1/2023, Main topic ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - Efficacy of maintenance therapy with the PARP inhibitor olaparib in platinum-sensitive recurrent ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2024, Case reports ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Current trends in the treatment of pancreatic cancer
MUDr. Ján Slopovský, MUDr. Benjamin Špánik, MUDr. Tomáš Šálek, MUDr. Natália Pazderová, MUDr. Mgr. Zuzana Mináriková, PhD., MUDr. Eva Zomborská, MUDr. Štefan Pörsök, PhD., MPH
(5/2022, Main topic ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Publikujeme v zahraničí
(2/2013, Information & comments ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - Updated ESMO recommendations for the treatment of newly diagnosed ovarian epithelial carcinoma
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2022, Review articles ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles )
- Contemporary approaches to genetic diagnostics in clinical oncology
RNDr. Regína Lohajová Behulová, PhD., Mgr. Michal Svoboda, RNDr. Aster Alemayehu, PhD., Mgr. Lukáš Šebest, PhD.
(2/2024, Main topic )